版本:
中国

BRIEF-Corbus Pharma says cystic fibrosis study data to be reported by Q1 2017 end

March 9 Corbus Pharmaceuticals Holdings Inc :

* Corbus Pharmaceuticals reports 2016 financial results and provides 2017 business update

* Topline data for phase 2 cystic fibrosis study expected to be reported by end of Q1 2017

* Company has sufficient capital to fund its operations into Q4 2018 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐